Announcement: Dr. David Hess re-appointed as Sheldon H. Weinstein Endowed Chair in Diabetes Research
I am pleased to announce Dr. David Hess has been re-appointed as the Sheldon H. Weinstein Endowed Chair in Diabetes Research at the Schulich School of Medicine & Dentistry, Western University, effective February 1, 2022 to January 31, 2027.
Dr. Hess earned a PhD in Pharmacology & Toxicology, Schulich Medicine & Dentistry, Western University, and completed his postdoctoral training at the School and at Washington University School of Medicine.
He was appointed as an Assistant Professor, Physiology & Pharmacology, Schulich Medicine & Dentistry, and a scientist in the Molecular Medicine Research Group at the Krembil Centre for Stem Cell Biology, as well as at the Division of Genetics & Development at the Children's Health Research Institute.
The focus of Dr. Hess’ research is to understand the mechanisms by which distinct stem cell subsets coordinate angiogenesis and tissue regeneration during diabetes and its cardiovascular complications.
Dr. Hess is interested in the development of cellular therapies to mediate the repair of diseased, damaged or ischemic tissues. Specific applications for his work include the use of transplanted human bone marrow and umbilical cord blood-derived stem cells to promote blood vessel formation and to regenerate insulin-producing beta cells during diabetes.
Dr. Hess has been the recipient of a number of awards, including the MacDonald Scholarship from the Heart and Stroke Foundation of Canada, postdoctoral fellowship awards from the Canadian Institutes of Health Research and studentships from the National Health Research and Development Program, Health Canada.
Please join me in congratulating Dr. Hess on his re-appointment.
John Yoo, MD, FRCS(C), FACS
Dean, Schulich School of Medicine & Dentistry
Western University
